Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: A modelling study

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Kypridemos, Chris ^a   Bandosz, Piotr ^a,b   Hickey, Graeme L ^a   Guzman Castillo, Maria ^a   Allen, Kirk ^a,c   Buchan, Iain ^d   Capewell, Simon ^a   O'Flaherty, Martin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c LANCASTER UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; PRIMARY PREVENTION; SOCIOECONOMICS; UNCERTAINTY; UNITED KINGDOM; ADOLESCENT; AGED; BLOOD; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVAL; ENGLAND; GENETICS; MIDDLE AGED; SOCIAL CLASS;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; CONFIDENCE INTERVALS; ENGLAND; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MONTE CARLO METHOD; SOCIAL CLASS;

EID: 84928902035     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123112     Document Type: Article

References (64)

1. Alwan A, Armstrong T, Bettcher D, Branca F, Chisholm D, Ezzati M, et al. (2011) Global status report on noncommunicable diseases 2010. World Health Organization. Available: http://whqlibdoc.who.int/publications/2011/9789240686458-eng.pdf.
2. Townsend N, Wickramasinghe K, Bhatnagar P, Smolina K, Nichols M, Leal J, et al. (2012) Coronary heart disease statistics 2012 edition. British Heart Foundation. Available: http://www.bhf.org.uk/publications/view-publication.aspx?ps=1002097.
3. Unal B, Critchley JA, Capewell S (2004) Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109: 1101-1107. doi: 10.1161/01.CIR.0000118498.35499.B2 PMID: 14993137
4. The Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (n.d.) Global Burden of Metabolic Risk Factors of Chronic Diseases. Available: http://www1.imperial.ac.uk/publichealth/departments/ebs/projects/eresh/majidezzati/healthmetrics/metabolicriskfactors/. Accessed 6 October 2014.
5. Morton GM, Lee SM, Buss DH, Lawrance P (1995) Intakes and major dietary sources of cholesterol and phytosterols in the British diet. J Hum Nutr Diet 8: 429-440. doi: 10.1111/j.1365-277X.1995.tb00338.x
6. Department of Health (n.d.) Pharmacies and prescriptions: statistics. Available: http://webarchive.nationalarchives.gov.uk/20120503222906/http:/www.dh.gov.uk/en/PublicationsAndStatistics/Statistics/StatisticalWorkAreas/StatisticalHealthCare/DH-4086488. Accessed 15 June 2014.
7. Scholes S, Bajekal M, Love H, Hawkins N, Raine R, O'Flaherty M, et al. (2012) Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: A time-trend analysis of repeated cross-sectional data. BMC Public Health 12: 129. doi: 10.1186/1471-2458-12-129 PMID: 22333887
8. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al. (2011) National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. The Lancet 377: 578-586. doi: 10.1016/S0140-6736(10)62038-7 PMID: 21295847
9. Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, Crouse JR, et al. (2010) 30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006. Am J Cardiol 106: 969-975. doi: 10.1016/j.amjcard.2010.05.030 PMID: 20854959
10. Pietinen P, Vartiainen E, Seppänen R, Aro A, Puska P (1996) Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med 25: 243-250. doi: 10.1006/pmed.1996.0053 PMID: 8781001
11. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al. (1993) Declining serum total cholesterol levels among US adults: The National Health and Nutrition Examination Surveys. JAMA 269: 3002-3008. doi: 10.1001/jama.1993.03500230084034 PMID: 8501842
12. Thorsson B, Steingrimsdottir L, Halldorsdottir S, Andersen K, Sigurdsson G, Aspelund T, et al. (2013) Changes in total cholesterol levels in Western societies are not related to statin, but rather dietary factors: the example of the Icelandic population. Eur Heart J 34: 1778-1782. doi: 10.1093/eurheartj/ehs395 PMID: 23209261
13. Eliasson M, Janlert U, Jansson JH, Stegmayr B (2006) Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med 260: 551-559. doi: 10.1111/j.1365-2796.2006.01730.x PMID: 17116006
14. Cífková R, ͆kodová Z, Bruthans J, Adámková V, Jozífová M, Galovcová M, et al. (2010) Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 211: 676-681. doi: 10.1016/j.atherosclerosis.2010.04.007 PMID: 20471016
15. Valsta LM, Tapanainen H, Sundvall J, Laatikainen T, Männistö S, Pietinen P, et al. (2010) Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr 13: 932-938. doi: 10.1017/S1368980010001126 PMID: 20513263
16. Blackman T (2007) Statins, saving lives, and shibboleths. BMJ 334: 902. doi: 10.1136/bmj.39163.563519.55 PMID: 17463464
17. Capewell S, Graham H (2010) Will cardiovascular disease prevention widen health inequalities? PLoS Med 7: e1000320. doi: 10.1371/journal.pmed.1000320 PMID: 20811492
18. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129: S1-S45. doi: 10.1161/01.cir.0000437738.63853.7a PMID: 24222016
19. National Institute for Health and Care Excellence (2014) Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE guidelines [CG181]. Available: http://www.nice.org.uk/Guidance/CG181. Accessed 26 August 2014.
20. Wise J (2014) Open letter raises concerns about NICE guidance on statins. BMJ 348: 3937. doi: 10.1136/bmj.g3937
21. Thompson R, Gerada C, Haslam D, Bamrah JS, Kendrick M, Malhotra A, et al. (2014) NICE statin letter: concerns about the latest NICE draft guidance on statins. Available: www.nice.org.uk/media/877/AC/NICE-statin-letter.pdf.
22. Department for Communities and Local Government (2011) English indices of deprivation 2010 - Publications - GOV.UK. Available: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2010. Accessed 26 August 2014.
23. NatCen Social Research, University College London. Department of Epidemiology and Public Health (2014) Health Survey for England, 2012 [computer file]. Colchester, Essex: UK Data Archive [distributor]. Available: http://dx.doi.org/10.5255/UKDA-SN-7480-1. Accessed 1 May 2014.
24. NatCen Social Research, University College London. Department of Epidemiology and Public Health (2013) Health Survey for England, 2011 [computer file]. Colchester, Essex: UK Data Archive [distributor]. Available: http://dx.doi.org/10.5255/UKDA-SN-7260-1. Accessed 1 May 2014.
25. Office of Population Censuses and Surveys. Social Survey Division (1997) Health Survey for England, 1991-1992: combined data file [computer file]. 2nd edition. Colchester, Essex: UK Data Archive [distributor]. Available: http://dx.doi.org/10.5255/UKDA-SN-3238-1. Accessed 1 May 2014.
26. Bridges S, Doyle M, Fuller E, Knott C, Mindell J, Moody A, et al. (2013) Health Survey for England 2012. Methods and documentation. Health and Social Care Information Centre. Available: http://www.hscic.gov.uk/catalogue/PUB13218/HSE2012-Methods-and-docs.pdf.
27. Boniface S, Bridges S, Craig R, Darton R, Fuller E, Hancock R, et al. (2012) Health Survey for England 2011. Methods and documentation. Health and Social Care Information Centre. Available: http://www.hscic.gov.uk/catalogue/PUB09300/HSE2011-Methods-and-docs.pdf.
28. UK Data Service (n.d.) Health Survey for England, 1991-1992: combined data file, documentation. Available: http://discover.ukdataservice.ac.uk/catalogue/?sn=3238&type=Data%20catalogue. Accessed 16 June 2014.
29. Office for National Statistics (2012) Standard Occupational Classification and Socio-Economic Classification: Archive. Available: http://www.ons.gov.uk/ons/guide-method/classifications/archived-standard-classifications/soc-and-sec-archive/index.html. Accessed 27 August 2014.
30. Capewell S, Ford ES (2011) Why have total cholesterol levels declined in most developed countries?BMC Public Health 11: 641. doi: 10.1186/1471-2458-11-641 PMID: 21834954
31. Capewell S, Morrison CE, McMurray JJ (1999) Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 81: 380-386. doi: 10.1136/hrt.81.4.380 PMID: 10092564
32. R Core Team (2014) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Available: http://www.R-project.org/.
33. Lumley T (2013) Survey: analysis of complex survey samples. Available: http://cran.r-project.org/web/packages/survey/index.html.
34. Korn LE, Graubard IB (1998) Confidence Intervals for Proportions with Small Expected Number of Positive Counts Estimated from Survey Data. Surv Methodol 24: 193-201.
35. Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326: 1423. doi: 10.1136/bmj.326.7404.1423 PMID: 12829554
36. Kong SX, Crawford SY, Gandhi SK, Seeger JD, Schumock GT, Lam NP, et al. (1997) Efficacy of 3-hy-droxy-3-methylglutaryl coenzyme A reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials. Clin Ther 19: 778-797. doi: 10.1016/S0149-2918(97)80102-6 PMID: 9377621
37. Edwards JE, Moore RA (2003) Statins in hypercholesterolaemia: A dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract 4: 18. doi: 10.1186/1471-2296-4-18 PMID: 14969594
38. Jones MD P, Kafonek MD S, Laurora PharmD I, Hunninghake MD D (1998) Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 81: 582-587. doi: 10.1016/S0002-9149(97)00965-X PMID: 9514454
39. Health and Social Care Information Centre (2013) Prescription Cost Analysis 2012. Available: http://www.hscic.gov.uk/searchcatalogue?productid=11412&q=rescription+cost+analysis&topics=0%2fPrescribing&sort=Relevance&size=10&page=1#top. Accessed 23 February 2014.
40. Health and Social Care Information Centre 1 Trevelyan Square (2012) Prescription Cost Analysis 2011. Available: http://www.hscic.gov.uk/pubs/prescostanalysis2011. Accessed 23 February 2014.
41. Cochran WG (1977) Sampling Techniques. 3rd edition. New York: John Wiley & Sons. 428 p.
42. Gatz DF, Smith L (1995) The standard error of a weighted mean concentration - I. Bootstrapping vs other methods. Atmos Environ 29: 1185-1193. doi: 10.1016/1352-2310(94)00210-C
43. Ekstrom C (2014) MESS: Miscellaneous esoteric statistical script. Available: http://CRAN.R-project.org/package=MESS.
44. Bajekal M, Scholes S, Love H, Hawkins N, O'Flaherty M, Raine R, et al. (2012) Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med 9: e1001237. doi: 10.1371/journal.pmed.1001237 PMID: 22719232
45. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335: 136. doi: 10.1136/bmj.39261.471806.55 PMID: 17615182
46. Collins GS, Altman DG (2012) Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 344: e4181-e4181. doi: 10.1136/bmj.e4181 PMID: 22723603
47. Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G (2007) Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner "Quality and Outcomes Framework." J Public Health 29: 40-47. doi: 10.1093/pubmed/fdl068 PMID: 17071815
48. Wu J, Zhu S, Yao GL, Mohammed MA, Marshall T (2013) Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study. PLoS ONE 8: e67611. doi: 10.1371/journal.pone.0067611 PMID: 23922649
49. Stocks NP, Ryan P, McElroy H, Allan J (2004) Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study. Med J Aust 180: 229-231. PMID: 14984343
50. Ohlsson H, Lynch K, Merlo J (2010) Is the physician's adherence to prescription guidelines associated with the patient's socio-economic position? An analysis of statin prescription in South Sweden. J Epidemiol Community Health 64: 678-683. doi: 10.1136/jech.2008.081166 PMID: 19692716
51. Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Bøggild H, Olsen J, et al. (2005) Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 60: 534-542. doi: 10.1111/j.1365-2125.2005.02494.x PMID: 16236044
52. Franks P, Tancredi D, Winters P, Fiscella K (2010) Cholesterol treatment with statins: Who is left out and who makes it to goal? BMC Health Serv Res 10: 68. doi: 10.1186/1472-6963-10-68 PMID: 20236527
53. Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, et al. (1981) Diet, serum cholesterol, and death from coronary heart disease: the Western Electric study. N Engl J Med 304: 65-70. doi: 10.1056/NEJM198101083040201 PMID: 7442730
54. Food and Agriculture Organization of the United Nations (2014) FAOSTAT. Available: http://faostat.fao.org/default.aspx. Accessed 16 June 2014.
55. Rose G (2001) Sick individuals and sick populations. Int J Epidemiol 30: 427-432. doi: 10.1093/ije/30. 3.427 PMID: 11416056
56. Ellis JJ, Erickson SR, Stevenson JG, Bemstein SJ, Stiles RA, Fendrick MA (2004) Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 19: 638-645. doi: 10.1111/j.1525-1497.2004.30516.x PMID: 15209602
57. Chaudhry HJ, McDermott B (2008) Recognizing and improving patient nonadherence to statin therapy. Curr Atheroscler Rep 10: 19-24. PMID: 18366981
58. Bouchard M-H, Dragomir A, Blais L, Berard A, Pilon D, Perreault S (2007) Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol 63: 698-708. doi: 10.1111/j.1365-2125.2006.02828.x PMID: 17214831
59. Wallach-Kildemoes H, Andersen M, Diderichsen F, Lange T (2013) Adherence to preventive statin therapy according to socioeconomic position. Eur J Clin Pharmacol 69: 1553-1563. doi: 10.1007/s00228-013-1488-6 PMID: 23588558
60. Sugiyama T, Tsugawa Y, Tseng C-H, Kobayashi Y, Shapiro MF (2014) Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins? JAMA Intern Med 174: 1038-1045. doi: 10.1001/jamainternmed.2014.1927 PMID: 24763487
61. Jørgensen T, Capewell S, Prescott E, Allender S, Sans S, Zdrojewski T, et al. (2013) Population-level changes to promote cardiovascular health. Eur J Prev Cardiol 20: 409-421. doi: 10.1177/2047487312441726 PMID: 22514213
62. Brunner EJ, Marmot MG, White IR, O'Brien JR, Etherington MD, Slavin BM, et al. (1993) Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 102: 195-207. doi: 10.1016/0021-9150(93)90162-N PMID: 8251006
63. Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K (2006) Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med 21: 1215-1221. doi: 10.1111/j.1525-1497.2006.00591.x PMID: 17105519
64. Hippisley-Cox J, Parker C, Coupland C, Vinogradova Y (2007) Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study. Heart 93: 1256-1262. doi: 10.1136/hrt.2006.110171 PMID: 17344333